On the contrary, Ahmed et al. showed that the loss of the ECM protein TGFβI is sufficient to induce specific resistance to paclitaxel and mitotic spindle abnormalities in ovarian cancer cells [97]. This evidence concerns the gene TGFBI and ovarian carcinoma.